Clofazimine (CFZ), a riminophenazine derivative and a crucial drug in the treatment of
lepromatous leprosy, has been reintroduced clinically to treat multidrug-resistant …

Abstract An LC–MS/MS method was developed and validated for bioanalysis of clofazimine
in human dried blood spot (DBS) samples in support of a clinical study on multidrug …

A simple, accurate and precise stability-indicating RP-HPLC method was developed for
estimation of clofarabine in parenteral formulation. Some known impurities like, alpha …

The high performance liquid chromatographic (HPLC) method of Gidoh, et al. has been
modified substantially to provide a simple, rapid, and relatively inexpensive procedure for …

The present research work discusses the systematic Quality by Design (QbD) enabled
development of a simple, rapid, economical, and stability-indicating high-performance liquid …

Quantitative determination of Clofarabine in their Pharmaceutical Dosage form was carried
out by Liquid chromatographic method. The aim of the present work was to develop a RP …

Background: Clofazimine is potentially useful for the treatment of disease due to multidrug
resistant Mycobacterium tuberculosis, as well as leprosy and certain chronic skin diseases …

ABSTRACT Clofazimine [N, 5-bis (4-chlorophenyl)-3-[(propane-2-yl) rimino]-3, 5-
dihydrophenazin-2-amine] is an antimycobacterial agent used as a second-line …

Clofazimine (CFZ), an old hydrophobic riminophenazine, has a wide range of
antimycobacterial activity ranging from leprosy to nontuberculous mycobacterial diseases …

To date, Barry et al.[l] and Dill et al.[2] have reported, respectively, a spectrophotometric and
a fluorometric method of assay for clofazimine in biological fluids and tissue homogenates …